نتائج البحث - "МАННОЗА"

1

Academic Journal

Recurrent cystitis: how to achieve perfection in treatment? ; Рецидивирующий цистит: как достичь совершенства в лечении?

المؤلفون: E. V. Kulchavenya, D. P. Kholtobin, E. V. Brizhatyuk, S. Yu. Shevchenko, L. S. Treyvish, E. V. Telina, Е. В. Кульчавеня, Д. П. Холтобин, Е. В. Брижатюк, С. Ю. Шевченко, Л. С. Трейвиш, Е. В. Телина

المصدر: Meditsinskiy sovet = Medical Council; № 4 (2024); 84-91 ; Медицинский Совет; № 4 (2024); 84-91 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: Цистениум II, lower urinary tract infections, treatment, cranberry extract, mannose, Cysthenium II, инфекции нижних мочевыводящих путей, лечение, экстракт клюквы, манноза

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/8179/7207; González de Llano D, Liu H, Khoo C, Moreno-Arribas MV, Bartolomé B. Some New Findings Regarding the Antiadhesive Activity of Cranberry Phenolic Compounds and Their Microbial-Derived Metabolites against Uropathogenic Bacteria. J Agric Food Chem. 2019;67(8):2166–2174. https://doi.org/10.1021/acs.jafc.8b05625.; Sivick KE, Mobley HL. Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun. 2010;78(2):568–585. https://doi.org/10.1128/IAI.01000-09.; Baron EJ, Miller JM, Weinstein MP, Richter SS, Gilligan PH, Thomson RB Jr et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis. 2013;57(4):e22–e121. https://doi.org/10.1093/cid/cit278.; Hisano M, Bruschini H, Nicodemo AC, Srougi M. Cranberries and lower urinary tract infection prevention. Clinics (Sao Paulo). 2012;67(6):661–668. https://doi.org/10.6061/clinics/2012(06)18.; Zhao S, Liu H, Gu L. American cranberries and health benefits – an evolving story of 25 years. J Sci Food Agric. 2020;100(14):5111–5116. https://doi.org/10.1002/jsfa.8882.; Occhipinti A, Germano A, Maffei ME. Prevention of Urinary Tract Infection with Oximacro, A Cranberry Extract with a High Content of A-Type Proanthocyanidins: A Pre-Clinical Double-Blind Controlled Study. Urol J. 2016;13(2):2640–2649. https://doi.org/10.22037/uj.v13i2.3190.; De Almeida Alvarenga L, Borges NA, Moreira LSG, Resende Teixeira KT, Carraro-Eduardo JC, Dai L et al. Cranberries – potential benefits in patients with chronic kidney disease. Food Funct. 2019;10(6):3103–3112. https://doi.org/10.1039/c9fo00375d.; Перепанова ТС, Синякова ЛА, Локшин КЛ. Цистит у женщин: клинические рекомендации. М.; 2021. 35 с. Режим доступа: https://cr.minzdrav.gov.ru/recomend/14_2.; Коган МИ, Набока ЮЛ, Ибишев ХС, Гудима ИА. Нестерильность мочи здорового человека – новая парадигма в медицине. Урология. 2014;(5):48–52. Режим доступа: https://urologyjournal.ru/archive/article/30323.; Whiteside SA, Razvi H, Dave S, Reid G, Burton JP. The microbiome of the urinary tract – a role beyond infection. Nat Rev Urol. 2015;12(2):81–90. https://doi.org/10.1038/nrurol.2014.361.; Kline KA, Lewis AL. Gram-Positive Uropathogens, Polymicrobial Urinary Tract Infection, and the Emerging Microbiota of the Urinary Tract. Microbiol Spectr. 2016;4(2):10.1128/microbiolspec.UTI-0012-2012. https://doi.org/10.1128/microbiolspec.UTI-0012-2012.; Alam Parvez S, Rahman D. Virulence Factors of Uropathogenic E. coli. In: Behzadi P (ed.). Microbiology of Urinary Tract Infections – Microbial Agents and Predisposing Factors. IntechOpen; 2019. https://doi.org/10.5772/intechopen.79557.; Beerepoot MA, ter Riet G, Nys S, van der Wal WM, de Borgie CA, de Reijke TM et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med. 2012;172(9):704–712. https://doi.org/10.1001/archinternmed.2012.777.; Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269–284. https://doi.org/10.1038/nrmicro3432.; González de Llano D, Moreno-Arribas MV, Bartolomé B. Cranberry Polyphenols and Prevention against Urinary Tract Infections: Relevant Considerations. Molecules. 2020;25(15):3523. https://doi.org/10.3390/molecules25153523.; Beerepoot M, Geerlings S. Non-Antibiotic Prophylaxis for Urinary Tract Infections. Pathogens. 2016;5(2):36. https://doi.org/10.3390/pathogens5020036.; Jagannathan V, Viswanathan P. Proanthocyanidins – will they effectively restrain conspicuous bacterial strains devolving on urinary tract infection? J Basic Microbiol. 2018;58(7):567–578. https://doi.org/10.1002/jobm.201800131.; Foo LY, Lu Y, Howell AB, Vorsa N. A-Type proanthocyanidin trimers from cranberry that inhibit adherence of uropathogenic P-fimbriated Escherichia coli. J Nat Prod. 2000;63(9):1225–1228. https://doi.org/10.1021/np000128u.; Gupta K, Chou MY, Howell A, Wobbe C, Grady R, Stapleton AE. Cranberry products inhibit adherence of p-fimbriated Escherichia coli to primary cultured bladder and vaginal epithelial cells. J Urol. 2007;177(6):2357–2360. https://doi.org/10.1016/j.juro.2007.01.114.; Di Martino P, Agniel R, David K, Templer C, Gaillard JL, Denys P, Botto H. Reduction of Escherichia coli adherence to uroepithelial bladder cells after consumption of cranberry juice: a double-blind randomized placebocontrolled cross-over trial. World J Urol. 2006;24(1):21–27. https://doi.org/10.1007/s00345-005-0045-z.; Howell AB. Bioactive compounds in cranberries and their role in prevention of urinary tract infections. Mol Nutr Food Res. 2007;51(6):732–737. https://doi.org/10.1002/mnfr.200700038.; Howell AB, Foxman B. Cranberry juice and adhesion of antibiotic-resistant uropathogens. JAMA. 2002;287(23):3082–3083. https://doi.org/10.1001/jama.287.23.3082.; Bononi M, Tateo F. Stabilization of cranberry anthocyanins in nutraceutical capsules. Int J Food Sci Nutr. 2007;58(2):142–149. https://doi.org/10.1080/09637480601154061.; Williams G, Hahn D, Stephens JH, Craig JC, Hodson EM. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2023;4(4):CD001321. https://doi.org/10.1002/14651858.CD001321.pub6.; Foxman B, Cronenwett AE, Spino C, Berger MB, Morgan DM. Cranberry juice capsules and urinary tract infection after surgery: results of a randomized trial. Am J Obstet Gynecol. 2015;213(2):194.e1–8. https://doi.org/10.1016/j.ajog.2015.04.003.; Scharf B, Schmidt TJ, Rabbani S, Stork C, Dobrindt U, Sendker J et al. Antiadhesive natural products against uropathogenic E. coli: What can we learn from cranberry extract? J Ethnopharmacol. 2020;257:112889. https://doi.org/10.1016/j.jep.2020.112889.; Scharf B, Sendker J, Dobrindt U, Hensel A. Influence of Cranberry Extract on Tamm-Horsfall Protein in Human Urine and its Antiadhesive Activity Against Uropathogenic Escherichia coli. Planta Med. 2019;85(2):126–138. https://doi.org/10.1055/a-0755-7801.; Кульчавеня ЕВ, Трейвиш ЛС, Телина ЕВ. Альтернативные виды терапии рецидивирующего цистита у женщин в менопаузе. Медицинский совет. 2022;(14):164–170. https://doi.org/10.21518/2079-701X-2022-16-14-164-170.; Sharon N. Carbohydrates as future anti-adhesion drugs for infectious diseases. Biochim Biophys Acta. 2006;1760(4):527–537. https://doi.org/10.1016/j.bbagen.2005.12.008.; Feenstra T, Thøgersen MS, Wieser E, Peschel A, Ball MJ, Brandes R et al. Adhesion of Escherichia coli under flow conditions reveals potential novel effects of FimH mutations. Eur J Clin Microbiol Infect Dis. 2017;36(3):467–478. https://doi.org/10.1007/s10096-016-2820-8.; Lenger SM, Bradley MS, Thomas DA, Bertolet MH, Lowder JL, Sutcliffe S. D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020;223(2):265.e1–265.e13. https://doi.org/10.1016/j.ajog.2020.05.048.; Konesan J, Wang J, Moore KH, Mansfield KJ, Liu L. Cranberry, but not D-mannose and ibuprofen, prevents against uropathogenic Escherichia coli-induced cell damage and cell death in MDCK cells. Front Microbiol. 2023;14:1319785. https://doi.org/10.3389/fmicb.2023.1319785.; Нашивочникова НА, Леанович ВЕ. Опыт применения растительных препаратов в комплексном лечении неосложненных инфекций нижних мочевыводящих путей у беременных. Урология. 2020;(5):33–36. https://doi.org/10.18565/urology.2020.5.33-36.; Нашивочникова НА, Крупин ВН. Профилактика рецидивов острого цистита. РМЖ. 2017;(8):503–505. Режим доступа: https://www.rmj.ru/articles/urologiya/Profilaktika_recidivov_ostrogo_cistita/.; Нашивочникова НА, Крупин ВН, Леанович ВЕ. Особенности профилактики и лечения неосложненных инфекций нижних мочевыводящих путей у беременных. РМЖ. Мать и дитя. 2021;4(2):119–123. https://doi.org/10.32364/2618-8430-2021-4-2-119-123.; Кравченко ЕН, Куклина ЛВ. Бессимптомная бактериурия беременных: оценка эффективности лечения. Женская клиника. 2022;(2):43–48. Режим доступа: https://elibrary.ru/rddiuu.; Нашивочникова НА, Леанович ВЕ. Клинико-патогенетические аспекты лечения и профилактики пиелонефрита у детей. Урология. 2022;(6):97–104. https://doi.org/10.18565/urology.2022.6.97-104.; Котов СВ, Перов РА. Комбинированная профилактика рецидивирующих воспалительных заболеваний нижних мочевыводящих путей у детей и беременных. Урология. 2020;(2):122–126. https://doi.org/10.18565/urology.2020.2.122-126.; Кульчавеня ЕВ. Контроль внелегочного туберкулеза в Сибири и на Дальнем Востоке. Проблемы туберкулеза и болезней легких. 2008;85(9):16–19. Режим доступа: https://elibrary.ru/mwdfll.; Kulchavenya E, Kholtobin D, Shevchenko S. Challenges in urogenital tuberculosis. World J Urol. 2020;38(1):89–94. https://doi.org/10.1007/s00345-019-02767-x.; https://www.med-sovet.pro/jour/article/view/8179

الاتاحة: https://www.med-sovet.pro/jour/article/view/8179
https://doi.org/10.21518/ms2024-101

View record in BASE

2

Academic Journal

Regarding the prospects of using Lactobacillus-based probiotics, D-mannose and cranberry extracts in therapy of urinary tract infections ; О перспективах применения лактобактериальных пробиотиков, D-маннозы и экстрактов клюквы в терапии инфекций мочевыводящих путей

المؤلفون: O. A. Gromova, I. Yu. Torshin, О. А. Громова, И. Ю. Торшин

المصدر: Obstetrics, Gynecology and Reproduction; Vol 17, No 4 (2023); 485-499 ; Акушерство, Гинекология и Репродукция; Vol 17, No 4 (2023); 485-499 ; 2500-3194 ; 2313-7347

مصطلحات موضوعية: систематический анализ данных, UTIs, Lactobacillus LC-11, D-mannose, standardized cranberry extract, Lactoflorene® Cist, systematic data analysis, ИМП, лактобациллы LC-11, D-манноза, стандартизированный экстракт клюквы, Lactoflorene® Цист

وصف الملف: application/pdf

Relation: https://www.gynecology.su/jour/article/view/1767/1136; Getaneh T., Negesse A., Dessie G. et al. Prevalence of urinary tract infection and its associated factors among pregnant women in Ethiopia: a systematic review and meta-analysis. Biomed Res Int. 2021;2021:6551526. https://doi.org/10.1155/2021/6551526.; Chelkeba L., Fanta K., Mulugeta T., Melaku T. Bacterial profile and antimicrobial resistance patterns of common bacteria among pregnant women with bacteriuria in Ethiopia: a systematic review and metaanalysis. Arch Gynecol Obstet. 2022;306(3):663–86. https://doi.org/10.1007/s00404-021-06365-4.; González-Garay A., Velasco-Hidalgo L., Ochoa-Hein E., Rivera-Luna R. Efficacy and safety of quinolones for the treatment of uncomplicated urinary tract infections in women: a network meta-analysis. Int Urogynecol J. 2021;32(1):3–15. https://doi.org/10.1007/s00192-020-04255-y.; Lenger S.M., Bradley M.S., Thomas D.A. et al. D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020;223(2):265.e1–265.e13. https://doi.org/10.1016/j.ajog.2020.05.048.; Зайцев А.В., Перепанова Т.С., Гвоздев М.Ю., Арефьева О.А. Инфекции мочевыводящих путей: методические рекомендации № 57. М.: АБВ-пресс, 2018. 26 с.; Delcaru C., Alexandru I., Podgoreanu P. et al. Microbial biofilms in urinary tract infections and prostatitis: etiology, pathogenicity, and combating strategies. Pathogens. 2016;5(4):65. https://doi.org/10.3390/pathogens5040065.; McMillan A., Dell M., Zellar M.P. et al. Disruption of urogenital biofilms by lactobacilli. Colloids Surf B Biointerfaces. 2011;86(1):58–64. https://doi.org/10.1016/j.colsurfb.2011.03.016.; Soto M. Importance of biofilms in urinary tract infections: new therapeutic approaches. Adv Biol. 2014;5:1–13. https://doi.org/10.1155/2014/543974.; Hall-Stoodley L., Costerton J.W., Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2004;2(2):95–108. https://doi.org/10.1038/nrmicro821.; Parsek M.R., Singh P.K. Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol. 2003;57:677–701. https://doi.org/10.1146/annurev.micro.57.030502.090720.; Imamura Y., Chandra J., Mukherjee P.K. et al. Fusarium and Candida albicans biofilms on soft contact lenses: model development, influence of lens type, and susceptibility to lens care solutions. Antimicrob Agents Chemother. 2008;52(1):171–82. https://doi.org/10.1128/AAC.00387-07.; Patterson J.L., Girerd P.H., Karjane N.W., Jefferson K.K. Effect of biofilm phenotype on resistance of Gardnerella vaginalis to hydrogen peroxide and lactic acid. Am J Obstet Gynecol. 2007;197(2):170.e1–7. https://doi.org/10.1016/j.ajog.2007.02.027.; Patterson J.L., Stull-Lane A., Girerd P.H., Jefferson K.K. Analysis of adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of Gardnerella vaginalis relative to other bacterial-vaginosisassociated anaerobes. Microbiology (Reading). 2010;156(Pt 2):392–9. https://doi.org/10.1099/mic.0.034280-0.; Swidsinski A., Mendling W., Loening-Baucke V. et al. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol. 2008;198(1):97.e1–6. https://doi.org/10.1016/j.ajog.2007.06.039.; Rogers A.H. Molecular oral microbiology. Caister Academic Press, 2008. 292 p. https://doi.org/10.21775/9781912530069.; Gondil V.S., Subhadra B. Biofilms and their role on diseases. BMC Microbiol. 2023;23(1):203. https://doi.org/10.1186/s12866-023-02954-2.; Garg S.S., Dubey R., Sharma S. et al. Biological macromolecules-based nanoformulation in improving wound healing and bacterial biofilmassociated infection: a review. Int J Biol Macromol. 2023;247:125636. https://doi.org/10.1016/j.ijbiomac.2023.125636.; Громова О.А., Торшин И.Ю. Микронутриенты и репродуктивное здоровье: руководство. M.: ГЭОТАР-Медиа, 2019. 672 с.; Tabasi M., Asadi Karam M.R., Habibi M. et al. Phenotypic assays to determine virulence factors of uropathogenic Escherichia coli (UPEC) isolates and their correlation with antibiotic resistance pattern. Osong Public Health Res Perspect. 2015;6(4):261–8. https://doi.org/10.1016/j.phrp.2015.08.002.; Komesu Y.M., Dinwiddie D.L., Richter H.E. et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Pelvic Floor Disorders Network. Defining the relationship between vaginal and urinary microbiomes. Am J Obstet Gynecol. 2020;222(2):154.e1–154.e10. https://doi.org/10.1016/j.ajog.2019.08.011.; Murina F., Graziottin A., Felice R., Di Francesco S. Coital pain in the elderly: could a low dose estriol gel thrill the vulvar vestibule? Eur J Obstet Gynecol Reprod Biol. 2016;207:121–4. https://doi.org/10.1016/j.ejogrb.2016.10.016.; Shim Y.H., Lee S.J., Lee J.W. Antimicrobial activity of lactobacillus strains against uropathogens. Pediatr Int. 2016;58(10):1009–13. https://doi.org/10.1111/ped.12949.; Schwendicke F., Korte F., Dörfer C.E. et al. Inhibition of Streptococcus mutans growth and biofilm formation by probiotics in vitro. Caries Res. 2017;51(2):87–95. https://doi.org/10.1159/000452960.; Gomes A.C., Hoffmann C., Mota J.F. Gut microbiota is associated with adiposity markers and probiotics may impact specific genera. Eur J Nutr. 2020;59(4):1751–62. https://doi.org/10.1007/s00394-019-02034-0.; Cannarella L.A.T., Mari N.L., Alcântara C.C. et al. Mixture of probiotics reduces inflammatory biomarkers and improves the oxidative/nitrosative profile in people with rheumatoid arthritis. Nutrition. 2021;89:111282. https://doi.org/10.1016/j.nut.2021.111282.; Громова О.А., Торшин И.Ю., Тетруашвили Н.К. Систематический анализ исследований по D-маннозе и перспективы ее применения при рецидивирующих инфекциях мочеполовых путей у женщин репродуктивного возраста. Акушерство, Гинекология и Репродукция. 2019;13(2):119–31. https://doi.org/10.17749/2313-7347.2019.13.2.119-131.; Торшин И.Ю., Аполихина И.А., Громов А.Н., Громова О.А. Свойства D-маннозы: противовоспалительный и противоопухолевый эффекты. Экспериментальная и клиническая урология. 2020;(2):164–70. https://doi.org/10.29188/2222-8543-2020-12-2-164-170.; Торшин И.Ю., Галустян А.Н., Иванова М.И. и др. Хемомикробиомный анализ синергизма D-маннозы и D-фруктозы в сравнении с другими метабиотиками. Эффективная фармакотерапия. 2020;16(20):22–31. https://doi.org/10.33978/2307-3586-2020-16-20-22-31.; Eden C.S., Hagberg L., Hanson L.A. et al. Adhesion of Escherichia coli in urinary tract infection. Ciba Found Symp. 1981;80:161–87. https://doi.org/10.1002/9780470720639.ch11.; Schaeffer A.J., Chmiel J.S., Duncan J.L., Falkowski W.S. Mannosesensitive adherence of Escherichia coli to epithelial cells from women with recurrent urinary tract infections. J Urol. 1984;131(5):906–10. https://doi.org/10.1016/s0022-5347(17)50706-5.; Agata N., Ohta M., Miyazawa H. et al. Serological response to P-fimbriae of Escherichia coli in patients with urinary tract infections. Eur J Clin Microbiol Infect Dis. 1989;8(2):156–9. https://doi.org/10.1007/BF01963903.; Nowicki B., Svanborg-Eden C., Hull R., Hull S. Molecular analysis and epidemiology of the Dr hemagglutinin of uropathogenic Escherichia coli. Infect Immun. 1989;57(2):446–51. https://doi.org/10.1128/iai.57.2.446-451.1989.; Cordeiro M.A., Werle C.H., Milanez G.P., Yano T. Curli fimbria: an Escherichia coli adhesin associated with human cystitis. Braz J Microbiol. 2016;47(2):414–6. https://doi.org/10.1016/j.bjm.2016.01.024.; Pani A., Valeria L., Dugnani S. et al. Pharmacodynamics of D-mannose in the prevention of recurrent urinary infections. J Chemother. 2022;34(7):459–64. https://doi.org/10.1080/1120009X.2022.2061184.; Toyota S., Fukushi Y., Katoh S. et al. Anti-bacterial defense mechanism of the urinary bladder. Role of mannose in urine. Nihon Hinyokika Gakkai Zasshi. 1989;80(12):1816–23. (In Japanese). https://doi.org/10.5980/jpnjurol1989.80.1816.; De Nunzio C., Bartoletti R., Tubaro A. et al. Role of D-mannose in the prevention of recurrent uncomplicated cystitis: state of the art and future perspectives. Antibiotics. 2021;10(4):373. https://doi.org/10.3390/antibiotics10040373.; Торшин И.Ю., Громова О.А. Под ред. А.Г. Чучалина А.Г. Микронутриенты против коронавирусов. Вчера, сегодня, завтра. M.: ГЭОТАРМедиа, 2023. 448 с.; Берников А.Н., Куприянов Ю.А., Строганов Р.В. и др. Симптомы нижних мочевыводящих путей и COVID-19. Урология. 2021;(5):78–83. https://doi.org/10.18565/urology.2021.5.78-83.; Mitrani-Gold F.S., Raychaudhuri A., Rao S. Systematic review and metaanalysis to estimate the antibacterial treatment effect of nitrofurantoin for a non-inferiority trial in uncomplicated urinary tract infection. J Glob Antimicrob Resist. 2020;22:68–77. https://doi.org/10.1016/j.jgar.2020.01.027.; Agresti A., Caffo B. Simple and effective confidence Intervals for proportions and differences of proportions result from adding two successes and two failures. Am Stat. 2000;54(4):280–8.; Falagas M.E., Vouloumanou E.K., Togias A.G. et al. Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2010;65(9):1862–77. https://doi.org/10.1093/jac/dkq237.; Alfaresi M., Hassan K., Alnjadat R.M.H. Single-dose Fosfomycin trometamol versus other antimicrobial regimens for treatment of uncomplicated lower urinary tract infection: a systematic review and meta-analysis. Open Microbiol J. 2019;13(1):193–9. https://doi.org/10.2174/1874285801913010193.; Kranjcec B., Papes D., Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol. 2014;32(1):79–84. https://doi.org/10.1007/s00345-013-1091-6.; Wagenlehner F., Lorenz H., Ewald O., Gerke P. Why D-mannose may be as efficient as antibiotics in the treatment of acute uncomplicated lower urinary tract infections-preliminary considerations and conclusions from a non-interventional study. Antibiotics. 2022;11(3):314. https://doi.org/10.3390/antibiotics11030314.; Kaur R., Kaur R. Symptoms, risk factors, diagnosis and treatment of urinary tract infections. Postgrad Med J. 2021;97(1154):803–12. https://doi.org/10.1136/postgradmedj-2020-139090.; Chiu K., Zhang F., Sutcliffe S. et al. Recurrent urinary tract infection incidence rates decrease in women with cystitis cystica after treatment with D-mannose: a cohort study. Female Pelvic Med Reconstr Surg. 2022;28(3):e62–e65. https://doi.org/10.1097/SPV.0000000000001144.; Harmidy K., Tufenkji N., Gruenheid S. Perturbation of host cell cytoskeleton by cranberry proanthocyanidins and their effect on enteric infections. PLoS One. 2011;6(11):e27267. https://doi.org/10.1371/journal.pone.0027267.; Howell A.B., Reed J.D., Krueger C.G. et al. A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry. 2005;66(18):2281–91. https://doi.org/10.1016/j.phytochem.2005.05.022.; Parazzini F., Ricci E., Fedele F. et al. Systematic review of the effect of D-mannose with or without other drugs in the treatment of symptoms of urinary tract infections/cystitis (Review). Biomed Rep. 2022;17(2):69. https://doi.org/10.3892/br.2022.1552.; Fu Z., Liska D., Talan D., Chung M. Cranberry reduces the risk of urinary tract infection recurrence in otherwise healthy women: a systematic review and meta-analysis. J Nutr. 2017;147(12):2282–8. https://doi.org/10.3945/jn.117.254961.; DE Leo V., Cappelli V., Massaro M.G. et al. Evaluation of the effects of a natural dietary supplement with cranberry, Noxamicina® and D-mannose in recurrent urinary infections in perimenopausal women. Minerva Ginecol. 2017;69(4):336–41. (In Italian). https://doi.org/10.23736/S0026-4784.17.04074-6.; Xia J.Y., Yang C., Xu D.F. et al. Consumption of cranberry as adjuvant therapy for urinary tract infections in susceptible populations: a systematic review and meta-analysis with trial sequential analysis. PLoS One. 2021;16(9):e0256992. https://doi.org/10.1371/journal.pone.0256992.; Raditic D.M. Complementary and integrative therapies for lower urinary tract diseases. Vet Clin North Am Small Anim Pract. 2015;45(4):857–78. https://doi.org/10.1016/j.cvsm.2015.02.009.; Vicariotto F. Effectiveness of an association of a cranberry dry extract, D-mannose, and the two microorganisms Lactobacillus plantarum LP01 and Lactobacillus paracasei LPC09 in women affected by cystitis: a pilot study. J Clin Gastroenterol. 2014;48 Suppl 1:S96–101. https://doi.org/10.1097/MCG.0000000000000224.; Murina F., Vicariotto F., Lubrano C. Efficacy of an orally administered combination of Lactobacillus paracasei LC11, cranberry and D-mannose for the prevention of uncomplicated, recurrent urinary tract infections in women. Urologia. 2021;88(1):64–68. https://doi.org/10.1177/0391560320957483.; https://www.gynecology.su/jour/article/view/1767

الاتاحة: https://www.gynecology.su/jour/article/view/1767
https://doi.org/10.17749/2313-7347/ob.gyn.rep.2023.442

View record in BASE

3

Academic Journal

Alternative therapies for recurrent cystitis in menopausal women ; Альтернативные виды терапии рецидивирующего цистита у женщин в менопаузе

المؤلفون: E. V. Kulchavenya, L. S. Treyvish, E. V. Telina, Е. В. Кульчавеня, Л. С. Трейвиш, Е. В. Телина

المصدر: Meditsinskiy sovet = Medical Council; № 14 (2022); 164-170 ; Медицинский Совет; № 14 (2022); 164-170 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: урогенитальные инфекции, urogenital syndrome, cystitis, chronic cystitis, D-mannose, urogenital infections, урогенитальный синдром, цистит, хронический цистит, D-манноза

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/7034/6327; Кульчавеня Е.В., Жукова И.И. Внелегочный туберкулез – вопросов больше, чем ответов. Туберкулез и болезни легких. 2017;95(2):59–63. https://doi.org/10.21292/2075-1230-2017-95-2-59-63.; Kulchavenya E., Kholtobin D., Shevchenko S. Challenges in urogenital tuberculosis. World J Urol. 2020;38(1):89–94. https://doi.org/10.1007/s00345-019-02767-x.; Hardy C.C., Keilich S.R., Harrison A.G., Knight B.E., Baker D.S., Smith P.P. The aging bladder phenotype is not the direct consequence of bladder aging. Neurourol Urodyn. 2019;38(8):2121–2129. https://doi.org/10.1002/nau.24149.; Hardy C.C., Al-Naggar I.M., Kuo C.-L., Kuchel G.A., Smith P.P. Aging changes in bladder hyperpolarization-activated cyclic nucleotide-gated channels are associated with increasing heterogeneity of adrenergic/mucosal influence on detrusor control in the mouse. J Gerontol A Biol Sci Med Sci. 2021;76(7):1153–1160. https://doi.org/10.1093/gerona/glab070.; Кульчавеня Е.В. Инфекции и секс: туберкулез и другие инфекции урогенитального тракта как причина сексуальных дисфункций. М.: ГЭОТАРМедиа; 2015. 168 с.; Bonkat G., Bartoletti R., Bruyère F., Cai T., Geerlings S.E., Koves S. et al. EAU guidelines on urological infections. EAU Guidelines Office, Arnhem, the Netherlands; 2020. 65 p. Available at: https://docs.yandex.ru/docs/view?tm=1655975639&tld=ru&lanq=en&name=7._2020_EAU_10_2021.pdf&text=Bonkat%20G.,%20Bartoletti%20R.,%20Bruy%C3%A8re%20F.,%20Cai%20T.,%20Geerlings%20S.E.,%20Koves%20S.%20et%20al.%20EAU%20guidelines%20on%20urological%20infections.%202021&url=https%3A%2F%2Fanest.vn.ua%2Ffile%2F7._2020_EAU_10_2021.pdf&lr=213&mime=pdf&l10n=ru&sign=7102115bbd0c744755f27b4effd3d030&keyno=0&nosw=1&serpParams=tm%3D1655975639%26tld%3Dru%26lang%3Den%26name%3D7._2020_EAU_10_2021.pdf%26text%3DBonkat%2BG.%252C%2BBartoletti%2BR.%252C%2BBruy%25C3%25A8re%2BF.%252C%2BCai%2BT.%252C%2BGeerlings%2BS.E.%252C%2BKoves%2BS.%2Bet%2Bal.%2BEAU%2Bguidelines%2Bon%2Burological%2Binfections.%2B2021%26url%3Dhttps%253A%2F%2Fanest.vn.ua%2Ffile%2F7._2020_EAU_10_2021.pdf%26lr%3D213%26mime%3Dpdf%26l10n%3Dru%26sign%3D7102115bbd0c744755f27b4effd3d030%26keyno%3D0%26nosw%3D1.; Кульчавеня Е.В., Брижатюк Е.В., Хомяков В.Т., Бреусов А.А. Частота возникновения цистита в зависимости от вида контрацепции. Урология. 2013;(1):41–43. Режим доступа: https://lib.medvestnik.ru/articles/Chastota-vozniknoveniya-cistita-v-zavisimosti-ot-vida-kontracepcii.html.; The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020;27(9):976–992. https://doi.org/10.1097/GME.0000000000001609.; Panay N. Genitourinary syndrome of the menopause – dawn of a new era? Climacteric. 2015;18(Suppl_1):13–17. https://doi.org/10.3109/13697137.2015.1070564.; Kyriakides R., Jones P., Somani B.K. Role of D-Mannose in the prevention of recurrent urinary tract infections: evidence from a systematic review of the literature. Eur Urol Focus. 2021;7(5):1166–1169. https://doi.org/10.1016/j.euf.2020.09.004.; Scaglione F., Musazzi U.M., Minghetti P. Considerations on D-mannose mechanism of action and consequent classification of marketed healthcare products. Front Pharmacol. 2021;12:636377. https://doi.org/10.3389/fphar.2021.636377.; Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010;7(12):653–660. https://doi.org/10.1038/nrurol.2010.190.; Eells S.J., Bharadwa K., McKinnell J.A., Miller L.G. Recurrent urinary tract infections among women: comparative effectiveness of 5 prevention and management strategies using a Markov chain Monte Carlo model. Clin Infect Dis. 2014;58(2):147–160. https://doi.org/10.1093/cid/cit646.; Lenger S.M., Bradley M.S., Thomas D.A., Bertolet M.H., Lowder J.L., Sutcliffe S. D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020;223(2):265.e1–265.e13. https://doi.org/10.1016/j.ajog.2020.05.048.; Ciani O., Grassi D., Tarricone R. An economic perspective on urinary tract infection: the “costs of resignation”. Clin Drug Investig. 2013;33(4):255–261. https://doi.org/10.1007/s40261-013-0069-x.; Renard J., Ballarini S., Mascarenhas T., Zahran M., Quimper E., Choucair J., Iselin C.E. Recurrent lower urinary tract infections have a detrimental effect on patient quality of life: a prospective, observational study. Infect Dis Ther. 2014;4(1):125–135. https://doi.org/10.1007/s40121-014-0054-6.; Sarshar M., Behzadi P., Ambrosi C., Zagaglia C., Palamara A.T., Scribano D. FimH and anti-adhesive therapeutics: a disarming strategy against uropathogens. Antibiotics (Basel). 2020;9(7):397. https://doi.org/10.3390/antibiotics9070397.; Berry R.E., Klumpp D.J., Schaeffer A.J. Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli. Infect Immun. 2009;77(7):2762–2772. https://doi.org/10.1128/IAI.00323-09.; Симаненков В.И., Маев И.В., Ткачева О.Н., Алексеенко С.А., Андреев Д.Н., Бордин Д.С. и др. Синдром повышенной эпителиальной проницаемости в клинической практике. мультидисциплинарный национальный консенсус. Кардиоваскулярная терапия и профилактика. 2021;20(1):2758. https://doi.org/10.15829/1728-8800-2021-2758.; Thänert R., Reske K.A., Hink T., Wallace M.A., Wang B., Schwartz D.J. et al. Comparative genomics of antibiotic-resistant uropathogens implicates three routes for recurrence of urinary tract infections. Am Soc Microbiol. 2019;10(4):e01977–e019819. https://doi.org/10.1128/mBio.01977-19.; Loubet P., Ranfaing J., Dinh A., Dunyach-Remy C., Bernard L., Bruyère F. et al. Alternative therapeutic options to antibiotics for the treatment of urinary tract infections. Front Microbiol. 2020;11:1509. https://doi.org/10.3389/fmicb.2020.01509.; Hu X., Shi Y., Zhang P., Miao M., Zhang T., Jiang B. D-Mannose: properties, production, and applications: An overview. Compr Rev Food Sci Food Saf. 2016;15(4):773–785. https://doi.org/10.1111/1541-4337.12211.; Zhang D., Chia C., Jiao X., Jin W., Kasagi S., Wu R. et al. D-mannose induces regulatory T cells and suppresses immunopathology. Nat Med. 2017;23(9):1036–1045. https://doi.org/10.1038/nm.4375.; Alton G., Hasilik M., Niehues R., Panneerselvam K., Etchison J.R., Fana F., Freeze H.H. Direct utilization of mannose for mammalian glycoprotein biosynthesis. Glycobiology. 1998;8(3):285–295. https://doi.org/10.1093/glycob/8.3.285.; Wellens A., Garofalo C., Nguyen H., Van Gerven N., Slättegård R., Hernalsteens J.-P. et al. Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complex. PLoS ONE. 2008;3(4):e2040. https://doi.org/10.1371/journal.pone.0002040.; Alton G., Kjaergaard S., Etchison J.R., Skovby F., Freeze H.H. Oral ingestion of mannose elevates blood mannose levels: a first step toward a potential therapy for carbohydrate-deficient glycoprotein syndrome type I. Biochem Mol Med. 1997;60(2):127–133. https://doi.org/10.1006/bmme.1997.2574.; Durán J.M., Cano M., Peral M.J., Ilundáin A.A. D-mannose transport and metabolism in isolated enterocytes. Glycobiology. 2004;14(6):495–500. https://doi.org/10.1093/glycob/cwh059.; Sharma V., Ichikawa M., Freeze H.H. Mannose metabolism: more than meets the eye. Biochem Biophys Res Commun. 2014;453(2):220–228. https://doi.org/10.1016/j.bbrc.2014.06.021.; Wei Z., Huang L., Cui L., Zhu X. Mannose: Good player and assister in pharmacotherapy. Biomed Pharmacother. 2020;129:110420. https://doi.org/10.1016/j.biopha.2020.110420.; Sharon N. Carboydrates as future anti-adhesion drugs for infectious diseases. Biochim Biophys Acta. 2006;1760(4):527–537. https://doi.org/10.1016/j.bbagen.2005.12.008.; Schaeffer A.J., Amundsen S.K., Jones J.M. Effect of carbohydrates on adherence of Escherichica coli to human urinary tract epithelial cells. Infect Immun. 1980;30(2):531–537. https://doi.org/10.1128/iai.30.2.531-537.1980.; Altarac S., Papeš D. Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU Int. 2014;113(1):9–10. https://doi.org/10.1111/bju.12492.; Zhou G., Mo W.J., Sebbel P., Min G., Neubert T.A., Glockshuber R. et al. Uroplakin Ia is the urothelial receptor for uropathogenic escherichia coli: evidence from in vitro fimh binding. J Cell Sci. 2001;114(Pt_22):4095–4103. https://doi.org/10.1242/jcs.114.22.4095.; Cusumano C.K., Pinkner J.S., Han Z., Greene S.E., Ford B.A., Crowley J.R. et al. Treatment and prevention of urinary tract infection with orally active FimH inhibitors. Sci Transl Med. 2011;3(109):109ra115. https://doi.org/10.1126/scitranslmed.3003021.; Aydin A., Ahmed K., Zaman I., Khan M.S., Dasgupta P. Recurrent urinary tract infections in women. Int Urogynecol J. 2015;26(6):795–804. https://doi.org/10.1007/s00192-014-2569-5.; Kalas V., Pinkner J.S., Hannan T.J., Hibbing M.E., Dodson K.W. et al. Evolutionary fine-tuning of conformational ensembles in FimH during host-pathogen interactions. Sci Adv. 2017;3(2):e1601944. https://doi.org/10.1126/sciadv.1601944.; Sauer M.M., Jakob R.P., Luber T., Canonica F., Navarra G., Ernst B. et al. Binding of the bacterial adhesin fimh to its natural, multivalent high-mannose type glycan targets. J Am Chem Soc. 2019;141(2):936–944. https://doi.org/10.1021/jacs.8b10736.; Pan Y.T., Xu B., Rice K., Smith S., Jackson R., Elbein A.D. Specificity of the high-mannose recognition site between Enterobacter cloacae pili adhesin and HT-29 cell membranes. Infect Immun. 1997;65(10):4199–4206. https://doi.org/10.1128/iai.65.10.4199-4206.1997.; Jones C.H., Pinkner J.S., Roth R., Heuser J., Nicholes A.V., Abraham S.N., Hultgren S.J. FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae. Proc Natl Acad Sci U S A. 1995;92(6):2081–2085. https://doi.org/10.1073/pnas.92.6.2081.; Poole N.M., Green S.I., Rajan A., Vela L.E., Zeng X.-L., Estes M.K., Maresso A.W. Role for FimH in extraintestinal pathogenic escherichia coli invasion and translocation through the intestinal epithelium. Infect Immun. 2017;85(11):e00581–e00587. https://doi.org/10.1128/IAI.00581-17.; Mydock-McGrane L.K., Hannan T.J., Janetka J.W. Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn’s disease. Expert Opin Drug Discov. 2017;12(7):711–731. https://doi.org/10.1080/17460441.2017.1331216.; Ohman L., Magnusson K.E., Stendahl O. Effect of monosaccharides and ethyleneglycol on the interaction between Escherichia coli bacteria and Octyl-Sepharose. Acta Pathol Microbiol Immunol Scand B. 1985;93(2): 133–138. https://doi.org/10.1111/j.1699-0463.1985.tb02864.x.; Feenstra T., Thøgersen M.S., Wieser E., Peschel A., Ball M.J., Brandes R. et al. Adhesion of Escherichia coli under flow conditions reveals potential novel effects of FimH mutations. Eur J Clin Microbiol Infect Dis. 2017;36(3):467–478. https://doi.org/10.1007/s10096-016-2820-8.; Ofek I., Goldhar J., Eshdat Y., Sharon N. The importance of mannose specific adhesins (lectins) in infections caused by Escherichia coli. Scand J Infect Dis Suppl. 1982;33:61–67. Available at: https://pubmed.ncbi.nlm.nih.gov/6753135/.; Schwartz D.J., Kalas V., Pinkner J.S., Chen S.L., Spaulding C.N., Dodson K.W., Hultgren S.J. Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation. Proc Natl Acad Sci U S A. 2013;110(39):15530–15537. https://doi.org/10.1073/pnas.1315203110.; Kranjčec B., Papeš D., Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol. 2014;32(1):79–84. https://doi.org/10.1007/s00345-013-1091-6.; Del Popolo G., Nelli F. Recurrent bacterial symptomatic cystitis: A pilot study on a new natural option for treatment. Arch Ital Urol Androl. 2018;90(2):101–103. https://doi.org/10.4081/aiua.2018.2.101.; Pugliese D., Acampora A., Porreca A., Schips L., Cindolo L. Effectiveness of a novel oral combination of D-Mannose, pomegranate extract, prebiotics and probiotics in the treatment of acute cystitis in women. Arch Ital Urol Androl. 2020;92(1):34–38. https://doi.org/10.4081/aiua.2020.1.34.; Phé V., Pakzad M., Haslam C., Gonzales G., Curtis C., Porter B. et al. Open label feasibility study evaluating D-mannose combined with home-based monitoring of suspected urinary tract infections in patients with multiple sclerosis. Neurourol Urodyn. 2017;36(7):1770–1775. https://doi.org/10.1002/nau.23173.; Parrino B., Schillaci D., Carnevale I., Giovannetti E., Diana P., Cirrincione G., Cascioferro S. Synthetic small molecules as anti-biofilm agents in the struggle against antibiotic resistance. Eur J Med Chem. 2019;161:154–178. https://doi.org/10.1016/j.ejmech.2018.10.036.; Mainini G., Passaro M., Schiattarella A., Franciscis P., Donna M.C.D., Trezza G. Prevention and treatment of cystitis during menopause: efficacy of a nutraceutical containing D-mannose, inulin, cranberry, bearberry, Olea europaea, Orthosiphon and Lactobacillus acidophilus. Prz Menopauzalny. 2020;19(3):130–134. https://doi.org/10.5114/pm.2020.99567.; Domenici L., Monti M., Bracchi C., Giorgini M., Colagiovanni V., Muzii L., Panici P.B. D-mannose: a promising support for acute urinary tract infections in women. A pilot study. Eur Rev Med Pharmacol Sci. 2016;20(13):2920–2925. Available at: https://pubmed.ncbi.nlm.nih.gov/27424995/.; Alton G., Hasilik M., Niehues R., Panneerselvam K., Etchison J.R., Fana F., Freeze H.H. Direct manipulation of mannose for mammalian glycoprotein biosynthesis. Glycobiology. 2001;8(3):285–295. https://doi.org/10.1093/glycob/8.3.285.; Davis J.A., Freeze H.H. Studies of mannose metabolism and effects of long-term mannose ingestion in the mouse. Biochim Biophys Acta. 2001; 1528(2–3):116–126. https://doi.org/10.1016/s0304-4165(01)00183-0.; Bouckaert J., Berglund J., Schembri M., De Genst E., Cools L., Wuhrer M. et al. Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin. Mol Microbiol. 2005;55(2):441–455. https://doi.org/10.1111/j.1365-2958.2004.04415.x.; Lopez A.I., Kumar A., Planas M.R., Li Y., Nguyen T.V., Cai C. Biofunctionalization of silicone polymers using poly (amidoamine) dendrimers and a mannose derivative for prolonged interference against pathogen colonization. Bimaterials. 2011;32(19):4336–4346. https://doi.org/10.1016/j.biomaterials.2011.02.056.; Franssen M., Cook J., Robinson J., Williams N., Glogowska M., Yang Y. et al. D-MannosE to prevent Recurrent urinary tract InfecTions (MERIT): protocol for a randomised controlled trial. BMJ Open. 2021;11(1):e037128. https://doi.org/10.1136/bmjopen-2020-037128.; Кузьменко А.В., Кузьменко В.В., Гяургиев Т.А. Эффективность комбинированной антибактериально-пребиотической терапии в сочетании с D-маннозой у женщин с неосложненной инфекцией нижних мочевых путей. Урология. 2019;(6):38–43. https://doi.org/10.18565/urology.2019.6.38-43.; Кузьмин И.В., Слесаревская М.Н., Аль-Шукри С.Х. Антиадгезивная стратегия неантибактериальной профилатики рецидивирующей инфекции нижних мочевыводящих путей. Урология. 2021;(3):5–12. https://doi.org/10.18565/urology.2021.3:5-12.; Тетерина Т.А., Ищук М.П., Аполихина И.А. Современные подходы к терапии и профилактике рецидивирующих циститов у беременных с применением D-маннозы: результаты проспективного рандомизированного клинического исследования. Эффективная фармакотерапия. 2021;17(9):6–14. Режим доступа: https://umedp.ru/articles/sovremennye_podkhody_k_terapii_i_profilaktike_retsidiviruyushchikh_tsistitov_u_beremennykh_s_primene.html.; https://www.med-sovet.pro/jour/article/view/7034

الاتاحة: https://www.med-sovet.pro/jour/article/view/7034
https://doi.org/10.21518/2079-701X-2022-16-14-164-170

View record in BASE

4

Academic Journal

Using of DNA-testing of cattle for the LTF and MBL1 genes to increase the milk production efficiency ; Применение ДНК-тестирования крупного рогатого скота по генам LTF и MBL1 для повышения эффективности производства молока

المؤلفون: V. Pestis K., V. Peshко V., О. Epishкo A., A. Sitko A., В. Пестис К., В. Пешко В., О. Епишко А., А. Ситько А.

المصدر: Doklady of the National Academy of Sciences of Belarus; Том 66, № 1 (2022); 122-128 ; Доклады Национальной академии наук Беларуси; Том 66, № 1 (2022); 122-128 ; 2524-2431 ; 1561-8323 ; 10.29235/1561-8323-2022-66-1

مصطلحات موضوعية: lactoferrin gene, mannose-binding leсtin gene, somatic cell count, economic efficiency, ген лактоферрина, ген манноза-связывающего лектина, количество соматических клеток, экономическая эффективность

وصف الملف: application/pdf

Relation: https://doklady.belnauka.by/jour/article/view/1046/1043; Лучко, И. Т. Воспаление молочной железы у коров (этиология, патогенез, диагностика, лечение и профилактика) / И. Т. Лучко. – Гродно, 2019. – 183 с.; Genetic basis of mastitis resistance in dairy cattle – a review / G. Sender [et al.] // Ann. Animal. Science. – 2013. – Vol. 13, N 4. – P. 663–673. https://doi.org/10.2478/aoas-2013-0043; Яковлев, А. Ф. Связь молекулярно-генетических маркеров с продолжительностью использования молочных коров / А. Ф. Яковлев, Н. В. Дементьева, В. П. Терлецкий // Генетика и разведение животных. – 2014. – № 4. – С. 3–7.; Confirmation and fine‐mapping of clinical mastitis and somatic cell score QTL in Nordic Holstein cattle / G. Sahana [et al.] // Animal Genetics. – 2013. – Vol. 44, N 6. – P. 620–626. https://doi.org/10.1111/age.12053; Database of cattle candidate genes and genetic markers for milk production and mastitis / J. Ogorevc [et al.] // Animal Genetics. – 2009. – Vol. 40, N 6. – P. 832–851. https://doi.org/10.1111/j.1365-2052.2009.01921.x; Differential expression of immune response genes associated with subclinical mastitis in dairy buffaloes / F. Tanamati [et al.] // Animal. – 2019. – Vol. 13, N 8. – P. 1651–1657. https://doi.org/10.1017/s1751731118003324; Genetics of resistance to clinical mastitis in cows: a review / O. M. Fedota [et al.] // Journal for Veterinary Medicine, Biotechnology and Biosafety. – 2015. – Vol. 1, N 4. – P. 22–27.; Mastitis in Dairy Animals: An Update / A. K. Srivastava [et al.]. – India, 2015. – 403 p.; Ogorevc, J. Аn integrated map of cattle candidate genes for mastitis: a step forward to new genetic markers / J. Ogorevc, T. Kunej, P. Dovc // 16th International Symposium “Animal Science Days”. – Strunjan, Slovenia, 2008. – P. 85–91.; Маниатис, Т. Молекулярное клонирование / Т. Маниатис, Э. Фрич, Дж. Сэмбрук. – М., 1984. – 480 с.; https://doklady.belnauka.by/jour/article/view/1046

الاتاحة: https://doklady.belnauka.by/jour/article/view/1046
https://doi.org/10.29235/1561-8323-2022-66-1-122-128

View record in BASE

5

Academic Journal

Non-antibacterial methods for the prevention and treatment of recurrent lower urinary tract infections ; Неантибактериальные методы профилактики и лечения рецидивирующих инфекций нижних мочевых путей

المؤلفون: N. D. Kubin, O. V. Volkova, D. D. Shkarupa, Н. Д. Кубин, О. В. Волкова, Д. Д. Шкарупа

المصدر: Urology Herald; Том 9, № 3 (2021); 92-106 ; Вестник урологии; Том 9, № 3 (2021); 92-106 ; 2308-6424 ; 10.21886/2308-6424-2021-9-3

مصطلحات موضوعية: фитотерапия, cystitis, non-antibacterial treatment, d-mannose, estrogens, nonsteroidal anti-inflammatory drugs, probiotics, glycosaminoglycans, immunostimulants, herbal medicine, цистит, неантибактериальное лечение, d-манноза, эстрогены, нестеройдные противовоспалительные средства, пробиотики, гликозаминогликаны, иммуностимуляторы

وصف الملف: application/pdf

Relation: https://www.urovest.ru/jour/article/view/477/344; Stamm WE, Norrby SR. Urinary tract infections: disease panorama and challenges. J Infect Dis. 2001;183 Suppl 1:S1- 4. DOI:10.1086/318850; Rafalskiy V, Khodnevich L. Prevalence and risk factors of uncomplicated uti: multicentre study sonar. Eur Urol Suppl. 2008;7(3):267. DOI:10.1016/s1569-9056(08)60781-2; Foxman B. Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs. Am J Med. 2002;113(1 SUPPL. 1):5-13. DOI:10.1016/S0002-9343(02)01054-9; Кульчавеня Е.В., Шевченко С.Ю., Чередниченко А.Г. Диагностика и лечение цистита: вопросов больше, чем ответов? Урология, 2016;5:37-42. eLIBRARY ID: 27390794; Flower A, Wang LQ, Lewith G, Liu JP, Li Q. Chinese herbal medicine for treating recurrent urinary tract infections in women. Cochrane Database Syst Rev. 2015;2015(6):CD010446. DOI:10.1002/14651858.CD010446.pub2; Christiaens TCM, De Meyere M, Verschraegen G, Peersman W, Heytens S, De Maeseneer JM. Randomised Controlled Trial of Nitro-Furantoin versus Placebo in the Treatment of Uncomplicated Urinary Tract Infection in Adult Women. 2002.; Ostrovsky DA, Ehrlich A. Canephron® N (BNO 1045) may be Non-inferior to Single-dose Fosfomycin in Reducing the Need for Additional Antibiotics to Treat Women with Presumptive Uncomplicated Urinary Tract Infections. Explore (NY). 2019;15(2):165-7. DOI:10.1016/j.explore.2018.12.008; Howell AB. Bioactive compounds in cranberries and their role in prevention of urinary tract infections. Mol Nutr Food Res. 2007;51(6):732-7. DOI:10.1002/mnfr.200700038; Avorn J, Monane M, Gurwitz JH, Glynn RJ, Choodnovskiy I, Lipsitz LA. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA. 1994;271(10):751-4. DOI:10.1001/jama.1994.03510340041031; Howell AB, Botto H, Combescure C, Blanc-Potard AB, Gausa L, Matsumoto T, Tenke P, Sotto A, Lavigne JP. Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study. BMC Infect Dis. 2010;10:94. DOI:10.1186/1471-2334-10-94; Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2012;10(10):CD001321. DOI:10.1002/14651858.CD001321.pub5; Luís Â, Domingues F, Pereira L. Can Cranberries Contribute to Reduce the Incidence of Urinary Tract Infections? A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Clinical Trials. J Urol. 2017;198(3):614-21. DOI:10.1016/j.juro.2017.03.078; McMurdo ME, Argo I, Phillips G, Daly F, Davey P. Cranberry or trimethoprim for the prevention of recurrent urinary tract infections? A randomized controlled trial in older women. J Antimicrob Chemother. 2009;63(2):389-95. DOI:10.1093/jac/dkn489; Schaeffer AJ, Chmiel JS, Duncan JL, Falkowski WS. Mannosesensitive adherence of Escherichia coli to epithelial cells from women with recurrent urinary tract infections. J Urol. 1984;131(5):906-10. DOI:10.1016/s0022-5347(17)50706-5; Spaulding CN, Klein RD, Ruer S, Kau AL, Schreiber HL, Cusumano ZT, Dodson KW, Pinkner JS, Fremont DH, Janetka JW, Remaut H, Gordon JI, Hultgren SJ. Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist. Nature. 2017;546(7659):528-32. DOI:10.1038/nature22972; Kranjčec B, Papeš D, Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol. 2014;32(1):79-84. DOI:10.1007/s00345-013-1091-6; Vicariotto F. Effectiveness of an association of a cranberry dry extract, D-mannose, and the two microorganisms Lactobacillus plantarum LP01 and Lactobacillus paracasei LPC09 in women affected by cystitis: a pilot study. J Clin Gastroenterol. 2014;48 Suppl 1:S96-101. DOI:10.1097/MCG.0000000000000224; Palleschi G, Carbone A, Zanello PP, Mele R, Leto A, Fuschi A, Al Salhi Y, Velotti G, Al Rawashdah S, Coppola G, Maurizi A, Maruccia S, Pastore AL. Prospective study to compare antibiosis versus the association of N-acetylcysteine, D-mannose and Morinda citrifolia fruit extract in preventing urinary tract infections in patients submitted to urodynamic investigation. Arch Ital Urol Androl. 2017;89(1):45-50. DOI:10.4081/aiua.2017.1.45; Lenger SM, Bradley MS, Thomas DA, Bertolet MH, Lowder JL, Sutcliffe S. D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020;223(2):265.e1-265.e13. DOI:10.1016/j.ajog.2020.05.048; Lipovac M, Kurz C, Reithmayr F, Verhoeven HC, Huber JC, Imhof M. Prevention of recurrent bacterial urinary tract infections by intravesical instillation of hyaluronic acid. Int J Gynaecol Obstet. 2007;96(3):192-5. DOI:10.1016/j.ijgo.2006.11.025; Nishimura M, Yan W, Mukudai Y, Nakamura S, Nakamasu K, Kawata M, Kawamoto T, Noshiro M, Hamada T, Kato Y. Role of chondroitin sulfate-hyaluronan interactions in the viscoelastic properties of extracellular matrices and fluids. Biochim Biophys Acta. 1998;1380(1):1-9. DOI:10.1016/s0304-4165(97)00119-0; Torella M, Schettino MT, Salvatore S, Serati M, De Franciscis P, Colacurci N. Intravesical therapy in recurrent cystitis: a multi-center experience. J Infect Chemother. 2013;19(5):920-5. DOI:10.1007/s10156-013-0609-6; Goddard JC, Janssen DAW. Intravesical hyaluronic acid and chondroitin sulfate for recurrent urinary tract infections: systematic review and meta-analysis. Int Urogynecol J. 2018;29(7):933-42. DOI:10.1007/s00192-017-3508-z; Кудрявцев Ю.В., Кирпатовский В.И., Перепанова Т.С., Хазан П.Л. Применение стабилизатора гликозаминогликанов – гиалуроната цинка, при экспериментальном моделировании острого бактериального и интерстициального цистита. Экспериментальная и клиническая урология. 2011;(1):39-44. eLIBRARY ID: 17331832; De Vita D, Antell H, Giordano S. Effectiveness of intravesical hyaluronic acid with or without chondroitin sulfate for recurrent bacterial cystitis in adult women: a meta-analysis. Int Urogynecol J. 2013;24(4):545-52. DOI:10.1007/s00192-012-1957-y; Lee BS, Bhuta T, Simpson JM, Craig JC. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev. 2012;10(10):CD003265. DOI:10.1002/14651858.CD003265.pub3; Forbes R, Ali A, Abouhajar A, Brennand C, Brown H, Carnell S, Chadwick T, Eardley I, Lecouturier J, Mossop H, Pearce I, Pickard R, Thiruchelvam N, Walton K, Wilkinson J, Harding C. ALternatives To prophylactic Antibiotics for the treatment of Recurrent urinary tract infection in women (ALTAR): study protocol for a multicentre, pragmatic, patient-randomised, non-inferiority trial. Trials. 2018;19(1):616. DOI:10.1186/s13063-018-2998-4; Hannan TJ, Roberts PL, Riehl TE, van der Post S, Binkley JM, Schwartz DJ, Miyoshi H, Mack M, Schwendener RA, Hooton TM, Stappenbeck TS, Hansson GC, Stenson WF, Colonna M, Stapleton AE, Hultgren SJ. Inhibition of Cyclooxygenase-2 Prevents Chronic and Recurrent Cystitis. EBioMedicine. 2014;1(1):46-57. DOI:10.1016/j.ebiom.2014.10.011; Gágyor I, Bleidorn J, Kochen MM, Schmiemann G, Wegscheider K, Hummers-Pradier E. Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: Randomised controlled trial. BMJ. 2015;351. DOI:10.1136/bmj.h6544; Kalle AM, Rizvi A. Inhibition of bacterial multidrug resistance by celecoxib, a cyclooxygenase-2 inhibitor. Antimicrob Agents Chemother. 2011;55(1):439-42. DOI:10.1128/AAC.00735-10; Schmidhammer S, Ramoner R, Höltl L, Bartsch G, Thurnher M, Zelle-Rieser C. An Escherichia coli-based oral vaccine against urinary tract infections potently activates human dendritic cells. Urology. 2002;60(3):521-6. DOI:10.1016/s0090-4295(02)01767-3; Волкова Е.В., Хоменков В.Г., Ахматова Э.А., Чалая Е.Л., Сорокина Е.В., Ахматова Н.К., Перепанова Т.С. Цитокиновый статус больных с рецидивирующей инфекцией нижних мочевых путей. Экспериментальная и клиническая урология. 2016;1:58-65. eLIBRARY ID: 29899520; Beerepoot MA, Geerlings SE, van Haarst EP, van Charante NM, ter Riet G. Nonantibiotic prophylaxis for recurrent urinary tract infections: a systematic review and meta-analysis of randomized controlled trials. J Urol. 2013;190(6):1981-9. DOI:10.1016/j.juro.2013.04.142; Naber KG, Cho YH, Matsumoto T, Schaeffer AJ. Immunoactive prophylaxis of recurrent urinary tract infections: a metaanalysis. Int J Antimicrob Agents. 2009;33(2):111-9. DOI:10.1016/j.ijantimicag.2008.08.011; Wagenlehner FM, Ballarini S, Pilatz A, Weidner W, Lehr L, Naber KG. A Randomized, Double-Blind, Parallel-Group, Multicenter Clinical Study of Escherichia coli-Lyophilized Lysate for the Prophylaxis of Recurrent Uncomplicated Urinary Tract Infections. Urol Int. 2015;95(2):167-76. DOI:10.1159/000371894; Naber KG, Bonkat G, Wagenlehner FME. The EAU and AUA/ CUA/SUFU Guidelines on Recurrent Urinary Tract Infections: What is the Difference? Eur Urol. 2020;78(5):645-6. DOI:10.1016/j.eururo.2020.06.032; Yang B, Foley S. First experience in the UK of treating women with recurrent urinary tract infections with the bacterial vaccine Uromune®. BJU Int. 2018;121(2):289-92. DOI:10.1111/bju.14067; Lorenzo-Gómez MF, Padilla-Fernández B, García-Criado FJ, Mirón-Canelo JA, Gil-Vicente A, Nieto-Huertos A, SilvaAbuin JM. Evaluation of a therapeutic vaccine for the prevention of recurrent urinary tract infections versus prophylactic treatment with antibiotics. Int Urogynecol J. 2013;24(1):127-34. DOI:10.1007/s00192-012-1853-5; Aziminia N, Hadjipavlou M, Philippou Y, Pandian SS, Malde S, Hammadeh MY. Vaccines for the prevention of recurrent urinary tract infections: a systematic review. BJU Int. 2019;123(5):753-68. DOI:10.1111/bju.14606; Prattley S, Geraghty R, Moore M, Somani BK. Role of Vaccines for Recurrent Urinary Tract Infections: A Systematic Review. Eur Urol Focus. 2020;6(3):593-604. DOI:10.1016/j.euf.2019.11.002; Lüthje P, Lindén Hirschberg A, Brauner A. Estrogenic action on innate defense mechanisms in the urinary tract. Maturitas. 2014;77(1):32-6. DOI:10.1016/j.maturitas.2013.10.018; Raz R, Stamm WE. A Controlled Trial of Intravaginal Estriol in Postmenopausal Women with Recurrent Urinary Tract Infections. N Engl J Med. 1993;329(11):753-6. DOI:10.1056/nejm199309093291102; Raz R, Colodner R, Rohana Y, Battino S, Rottensterich E, Wasser I, Stamm W. Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women. Clin Infect Dis. 2003;36(11):1362- 8. DOI:10.1086/374341; Xu R, Wu Y, Hu Y. [Prevention and treatment of recurrent urinary system infection with estrogen cream in postmenopausal women]. Zhonghua Fu Chan Ke Za Zhi. 2001;36(9):531-3. (In Chinese). PMID: 11769665; Perrotta C, Aznar M, Mejia R, Albert X, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev. 2008;(2):CD005131. DOI:10.1002/14651858.CD005131.pub2; Chen YC, Chang CC, Chiu THT, Lin MN, Lin CL. The risk of urinary tract infection in vegetarians and non-vegetarians: a prospective study. Sci Rep. 2020;10(1). DOI:10.1038/s41598-020-58006-6; Wilson JD. Bacterial vaginosis: going full circle? Sex Transm Infect. 2017;93(3):220. DOI:10.1136/sextrans-2016-053014; Gupta K, Stapleton AE, Hooton TM, Roberts PL, Fennell CL, Stamm WE. Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections. J Infect Dis. 1998;178(2):446-50. DOI:10.1086/515635; Mezzasalma V, Manfrini E, Ferri E, Boccarusso M, Di Gennaro P, Schiano I, Michelotti A, Labra M. Orally administered multispecies probiotic formulations to prevent uro-genital infections: a randomized placebo-controlled pilot study. Arch Gynecol Obstet. 2017;295(1):163-72. DOI:10.1007/s00404-016-4235-2; Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, Bruce AW. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol. 2003;35(2):131-4. DOI:10.1016/S0928-8244(02)00465-0; Colodner R, Edelstein H, Chazan B, Raz R. Vaginal colonization by orally administered Lactobacillus rhamnosus GG. Isr Med Assoc J. 2003;5(11):767-9. PMID: 14650098; Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ. 2001;322(7302):1571. DOI:10.1136/bmj.322.7302.1571; Schwenger EM, Tejani AM, Loewen PS. Probiotics for preventing urinary tract infections in adults and children. Cochrane Database Syst Rev. 2015;(12):CD008772. DOI:10.1002/14651858.CD008772.pub2; Ng QX, Peters C, Venkatanarayanan N, Goh YY, Ho CYX, Yeo WS. Use of Lactobacillus spp. to prevent recurrent urinary tract infections in females. Med Hypotheses. 2018;114:49- 54. DOI:10.1016/j.mehy.2018.03.001; Kim HY, Lee SJ, Lee DS, Yoo JM, Choe HS. Microbiological Characteristics of Unresolved Acute Uncomplicated Cystitis. Microb Drug Resist. 2016;22(5):387-91. DOI:10.1089/mdr.2015.0241; Paalanne N, Husso A, Salo J, Pieviläinen O, Tejesvi MV, Koivusaari P, Pirttilä AM, Pokka T, Mattila S, Jyrkäs J, Turpeinen A, Uhari M, Renko M, Tapiainen T. Intestinal microbiome as a risk factor for urinary tract infections in children. Eur J Clin Microbiol Infect Dis. 2018;37(10):1881- 91. DOI:10.1007/s10096-018-3322-7; Magruder M, Sholi AN, Gong C, Zhang L, Edusei E, Huang J, Albakry S, Satlin MJ, Westblade LF, Crawford C, Dadhania DM, Lubetzky M, Taur Y, Littman E, Ling L, Burnham P, De Vlaminck I, Pamer E, Suthanthiran M, Lee JR. Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection. Nat Commun. 2019;10(1):5521. DOI:10.1038/s41467-019-13467-w; Hocquart M, Pham T, Kuete E, Tomei E, Lagier JC, Raoult D. Successful Fecal Microbiota Transplantation in a Patient Suffering From Irritable Bowel Syndrome and Recurrent Urinary Tract Infections. Open Forum Infect Dis. 2019;6(10):ofz398. DOI:10.1093/ofid/ofz398; Tariq R, Pardi DS, Tosh PK, Walker RC, Razonable RR, Khanna S. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Reduces Recurrent Urinary Tract Infection Frequency. Clin Infect Dis. 2017;65(10):1745- 7. DOI:10.1093/cid/cix618; Yoon BI, Kim SW, Ha US, Sohn DW, Cho YH. Risk factors for recurrent cystitis following acute cystitis in female patients. J Infect Chemother. 2013;19(4):727-31. DOI:10.1007/s10156-013-0556-2; Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE. Risk factors for recurrent urinary tract infection in young women. J Infect Dis. 2000;182(4):1177-82. DOI:10.1086/315827; Tomas ME, Getman D, Donskey CJ, Hecker MT. Overdiagnosis of Urinary Tract Infection and Underdiagnosis of Sexually Transmitted Infection in Adult Women Presenting to an Emergency Department. J Clin Microbiol. 2015;53(8):2686- 92. DOI:10.1128/JCM.00670-15; Кульчавеня ЕВ, Шевченко СЮ. Особенности лечения больных посткоитальным циститом (предварительные результаты). Медицина и образование в Сибири. 2015;2:23. eLIBRARY ID: 26027161; Foxman B, Frerichs RR. Epidemiology of urinary tract infection: II. Diet, clothing, and urination habits. Am J Public Health. 1985;75(11):1314-7. DOI:10.2105/ajph.75.11.1314; Nseir W, Taha M, Nemarny H, Mograbi J. The association between serum levels of vitamin D and recurrent urinary tract infections in premenopausal women. Int J Infect Dis. 2013;17(12):e1121-4. DOI:10.1016/j.ijid.2013.06.007; Arnljots R, Snaebjörnsson Arnljots E, Thorn J, Elm M, Moore M, Sundvall PD. Bacteriuria and vitamin D deficiency: a cross sectional study of 385 nursing home residents. BMC Geriatr. 2019;19(1):381. DOI:10.1186/s12877-019-1400-z; Hooton TM, Vecchio M, Iroz A, Tack I, Dornic Q, Seksek I, Lotan Y. Effect of Increased Daily Water Intake in Premenopausal Women With Recurrent Urinary Tract Infections: A Randomized Clinical Trial. JAMA Intern Med. 2018;178(11):1509-15. DOI:10.1001/jamainternmed.2018.4204; Hunt JC, Waller G. Psychological factors in recurrent uncomplicated urinary tract infection. Br J Urol. 1992;69(5):460-4. DOI:10.1111/j.1464-410x.1992.tb15588.x; Cai T, Mazzoli S, Migno S, Malossini G, Lanzafame P, Mereu L, Tateo S, Wagenlehner FM, Pickard RS, Bartoletti R. Development and validation of a nomogram predicting recurrence risk in women with symptomatic urinary tract infection. Int J Urol. 2014;21(9):929-34. DOI:10.1111/iju.12453; https://www.urovest.ru/jour/article/view/477

الاتاحة: https://www.urovest.ru/jour/article/view/477
https://doi.org/10.21886/2308-6424-2021-9-3-92-106

View record in BASE

6

Academic Journal

SYNTHESIS AND PROPERTIES OF NEOGLYCOLIPIDS BASED ON 2-AMINO-2-HYDROXYMETHYLPROPANE-1,3-DIOL

المؤلفون: E. D. Shuina, I. S. Shchelik, Yu. L. Sebyakin

المصدر: Тонкие химические технологии, Vol 12, Iss 4, Pp 65-74 (2017)

مصطلحات موضوعية: d-манноза, tris, trivalent neoglycoconjugate, d-mannose, aggregates, antibacterial action, Chemistry, QD1-999

وصف الملف: electronic resource

Relation: https://www.finechem-mirea.ru/jour/article/view/106; https://doaj.org/toc/2410-6593; https://doaj.org/toc/2686-7575

URL الوصول: https://doaj.org/article/e3fb0546fcbf43939b231a1828e6f978

View record in DOAJ

7

Academic Journal

Systematic analysis of research on D-mannose and the prospects for its use in recurrent infections of the urinary tract in women of reproductive age ; Систематический анализ исследований по D-маннозе и перспективы ее применения при рецидивирующих инфекциях мочеполовых путей у женщин репродуктивного возраста

المؤلفون: O. A. Gromova, I. Yu. Torshin, N. K. Tetruashvili, О. А. Громова, И. Ю. Торшин, Н. К. Тетруашвили

المساهمون: The study was supported by the Russian Foundation for Вasic Research, grants № 17-07-00935 и № 18-07-01022., Работа поддержана грантами Российского фонда фундаментальных исследований № 17-07-00935 и № 18-07-01022.

المصدر: Obstetrics, Gynecology and Reproduction; Vol 13, No 2 (2019); 119-131 ; Акушерство, Гинекология и Репродукция; Vol 13, No 2 (2019); 119-131 ; 2500-3194 ; 2313-7347

مصطلحات موضوعية: анализ больших данных, pregnancy, infertility, reproductive age, uropathogenic Escherichia coli strains, D-mannose, big data analysis, беременность, бесплодие, репродуктивный возраст, уропатогенные штаммы Escherichia coli, D-манноза

وصف الملف: application/pdf

Relation: https://www.gynecology.su/jour/article/view/562/739; Caron F., Galperine T., Flateau C. et al. Practice guidelines for the management of adult community-acquired urinary tract infections. Med Mal Infect. 2018;48(5):327–58. DOI:10.1016/j. medmal.2018.03.005. PMID: 29759852.; Ghouri F., Hollywood A., Ryan K. A systematic review of non-antibiotic measures for the prevention of urinary tract infections in pregnancy. BMC Pregnancy Childbirth. 2018;18(1):99. DOI:10.1186/s12884-018-1732-2. PMID: 29653573.; Gregory D.S., Wu V., Tuladhar P. The pregnant patient: managing common acute medical problems. Am Fam Physician. 2018;98(9):595–602. PMID: 30325641.; Medus M.L., Gomez G.E., Zacchi L.F. et al. N-glycosylation triggers a dual selection pressure in eukaryotic secretory proteins. Sci Rep. 2017;7(1):8788. DOI:10.1038/s41598-017-09173-6. PMID: 28821844.; Maverakis E., Kim K., Shimoda M. et al. Glycans in the immune system and the altered glycan theory of autoimmunity: a critical review. J Autoimmun. 2015;57:1–13. DOI:10.1016/j.jaut.2014.12.002. PMID: 25578468.; Rushforth K. Trees of Britain and Europe (Collins Wild Guide). Harpercollins Pub Ltd, 1999. 1336 p.; Postma P.W., Lengeler J.W., Jacobson G.R. Phosphoenolpyruvate: carbohydrate phosphotransferase systems of bacteria. Microbiol Rev. 1993;57(3):543–94. PMID: 8246840.; Torshin I.Yu., Rudakov K.V. Combinatorial analysis of the solvability properties of the problems of recognition and completeness of algorithmic models. Part 1: factorization approach. Pattern Recognition and Image Analysis: Advances in Mathematical Theory and Applications. 2017;27(1):16–28.; Torshin I.Yu., Rudakov K.V. On the theoretical basis of metric analysis of poorly formalized problems of recognition and classification. Pattern Recognition and Image Analysis: Advances in Mathematical Theory and Applications. 2015;25(4):577–87.; Torshin I.Yu., Rudakov K.V. On metric spaces arising during formalization of problems of recognition and classification. Part 1: properties of compactness. Pattern Recognition and Image Analysis: Advances in Mathematical Theory and Applications. 2016;26(2):274–84.; Torshin I.Yu., Rudakov K.V. On metric spaces arising during formalization of problems of recognition and classification. Part 2: density properties. Pattern Recognition and Image Analysis: Advances in Mathematical Theory and Applications. 2016;26(3):483–96.; Торшин И.Ю., Гусев Е.И., Громова О.А. и др. Мировой опыт изучения эффектов омега-3 полиненасыщенных жирных кислот: влияние на когнитивный потенциал и некоторые психические расстройства. Журнал неврологии и психиатрии им. C.C. Корсакова. 2011;111(11):79–86. PMID: 22611686.; Громова О.А., Торшин И.Ю., Калачева А.Г. и др. Перспективы использования стандартизированных форм омега-3 полиненасыщенных жирных кислот в неврологии. Журнал неврологии и психиатрии им. C.C. Корсакова. 2012;112(1):101–5. PMID: 22701885.; Torshin I.Yu., Rudakov K.V. Combinatorial analysis of the solvability properties of the problems of recognition and completeness of algorithmic models. Part 2: metric approach within the framework of the theory of classification of feature values. Pattern Recognition and Image Analysis: Advances in Mathematical Theory and Applications. 2017;27(2):184–99.; Kondrashova M.N., Doliba N.M. Polarographic observation of substrate-level phosphorylation and its stimulation by acetylcholine. FEBS Letters. 1989;243(2):153–5. PMID: 2917643.; Vlahopoulos S., Gritzapis A.D., Perez S.A. et al. Mannose addition by yeast Pichia Pastoris on recombinant HER-2 protein inhibits recognition by the monoclonal antibody herceptin. Vaccine. 2009;27(34):4704–8. DOI:10.1016/j.vaccine.2009.05.063. PMID: 19520203.; Lee S.J., Evers S., Roeder D. et al. Mannose receptor-mediated regulation of serum glycoprotein homeostasis. Science. 2002;295(5561):1898–901. DOI:10.1126/science.1069540. PMID: 11884756.; Szolnoky G., Bata-Csorgo Z., Kenderessy A.S. et al. A mannose-binding receptor is expressed on human keratinocytes and mediates killing of Candida albicans. J Invest Dermatol. 2001;117(2):205–13. DOI:10.1046/j.1523-1747.2001.14071.x. PMID: 11511295.; Gazi U., Martinez-Pomares L. Influence of the mannose receptor in host immune responses. Immunobiology. 2009;214(7):554–61. DOI:10.1016/j.imbio.2008.11.004. PMID: 19162368.; Armelle J. Recurrent cystisis: No medicine preventive means. Prog Urol. 2017;27(14):823–30. DOI:10.1016/j.purol.2017.09.006. PMID: 29033364.; Eden C.S., Hagberg L., Hanson L.A. et al. Adhesion of Escherichia coli in urinary tract infection. Ciba Found Symp. 1981;80:161–87. PMID: 6114819.; Tabasi M., Asadi Karam M.R., Habibi M. et al. Phenotypic assays to determine virulence factors of uropathogenic Escherichia coli (UPEC) isolates and their correlation with antibiotic resistance pattern. Osong Public Health Res Perspect. 2015;6(4):261–8. DOI:10.1016/j.phrp.2015.08.002. PMID: 26473094.; Schaeffer A.J., Chmiel J.S., Duncan J.L., Falkowski W.S. Mannose-sensitive adherence of Escherichia coli to epithelial cells from women with recurrent urinary tract infections. J Urol. 1984;131(5):906–10. PMID: 6142969.; Agata N., Ohta M., Miyazawa H. et al. Serological response to P-fimbriae of Escherichia coli in patients with urinary tract infections. Eur J Clin Microbiol Infect Dis. 1989;8(2):156–9. PMID: 2566483.; Cordeiro M.A., Werle C.H., Milanez G.P., Yano T. Curli fimbria: an Escherichia coli adhesin associated with human cystitis. Braz J Microbiol. 2016;47(2):414–6. DOI:10.1016/j.bjm.2016.01.024. PMID: 26991275.; Nowicki B., Svanborg-Eden C., Hull R., Hull S. Molecular analysis and epidemiology of the Dr hemagglutinin of uropathogenic Escherichia coli. Infect Immun. 1989;57(2):446–51. PMID: 2643568.; Johnson J.R. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev. 1991;4(1):80–128. PMID: 1672263.; Monard A., Benoit G., Jacques L., Jardin A. Frequency of adherent colibacillus in a population with acute pyelonephritis and a population with acute cystitis. Prog Urol. 1993;3(4):583–9. PMID: 8104638.; Terai A., Yamamoto S., Mitsumori K. et al. Escherichia coli virulence factors and serotypes in acute bacterial prostatitis. Int J Urol. 1997;4(3):289–94. PMID: 9255669.; Domingue G.J., Roberts J.A., Laucirica R. et al. Pathogenic significance of P-fimbriated Escherichia coli in urinary tract infections. J Urol. 1985;133(6):983–9. PMID: 2860251.; Wellens A., Garofalo C., Nguyen H. et al. Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complex. PLoS One. 2008;3(4):e2040. DOI:10.1371/journal.pone.0002040. PMID: 18446213.; Subramanian P., Barka-Bouaifel F., Bouckaert J. et al. Graphene-coated surface plasmon resonance interfaces for studying the interactions between bacteria and surfaces. ACS Appl Mater Interfaces. 2014;6(8):5422–31. DOI:10.1021/am405541z. PMID: 24433135.; Toyota S., Fukushi Y., Katoh S. et al. Anti-bacterial defense mechanism of the urinary bladder. Role of mannose in urine. Nihon Hinyokika Gakkai Zasshi. 1989;80(12):1816–23. PMID: 2576290.; Domenici L., Monti M., Bracchi C. et al. D-mannose: a promising support for acute urinary tract infections in women. A pilot study. Eur Rev Med Pharmacol Sci. 2016;20(13):2920–5. PMID: 27424995.; Kranjcec B., Papes D., Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol. 2014;32(1):79–84. DOI:10.1007/s00345-013-1091-6. PMID: 23633128.; Marchiori D., Zanello P.P. Efficacy of N-acetylcysteine, D-mannose and Morinda citrifolia to treat recurrent cystitis in breast cancer survivals. In Vivo. 2017;31(5):931–6. DOI:10.21873/invivo.11149. PMID: 28882961.; Del Popolo G., Nelli F. Recurrent bacterial symptomatic cystitis: A pilot study on a new natural option for treatment. Arch Ital Urol Androl. 2018;90(2):101–3. DOI:10.4081/aiua.2018.2.101. PMID: 29974728.; Howell A.B., Reed J.D., Krueger C.G. et al. A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry. 2005;66(18):2281–91. DOI:10.1016/j.phytochem.2005.05.022. PMID: 16055161.; De Leo V., Cappelli V., Massaro M.G. et al. Evaluation of the effects of a natural dietary supplement with cranberry, Noxamicina® and D-mannose in recurrent urinary infections in perimenopausal women. Minerva Ginecol. 2017;69(4):336–41. DOI:10.23736/S0026- 4784.17.04074-6. PMID: 28608666.; Vicariotto F. Effectiveness of an association of a cranberry dry extract, D-mannose, and the two microorganisms Lactobacillus plantarum LP01 and Lactobacillus paracasei LPC09 in women affected by cystitis: a pilot study. J Clin Gastroenterol. 2014;48(Suppl 1):S96–101. DOI:10.1097/MCG.0000000000000224. PMID: 25291140.; Fu Z., Liska D., Talan D., Chung M. Cranberry reduces the risk of urinary tract infection recurrence in otherwise healthy women: a systematic review and meta-analysis. J Nutr. 2017;147(12):2282–8. DOI:10.3945/jn.117.254961. PMID: 29046404.; https://www.gynecology.su/jour/article/view/562

الاتاحة: https://www.gynecology.su/jour/article/view/562
https://doi.org/10.17749/2313-7347.2019.13.2.119-131

View record in BASE